Schedule 13D ownership disclosure
Vera Therapeutics Inc
Security class unavailable · CUSIP: 92337R101
Event date: 2022-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,970,156
- Percent of class
- 11.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-22-000551
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- Apr 07, 2022
- Reporting period
- Mar 28, 2022
- Description
- Schedule 13D beneficial ownership